PALO ALTO, Calif., Oct. 19, 2020 /PRNewswire/
-- Varian (NYSE: VAR), a leading provider of cancer care
technologies and solutions, continues to reinforce its commitment
to delivering Intelligent Cancer Care™ during the 2020
American Society for Radiation Oncology (ASTRO) taking place
virtually from October 24-31. At this
year's show, the company will showcase its progress in helping more
people access advanced cancer care, making cancer care more
personalized, and delivering more data-driven insights to improve
efficiencies and outcomes. In addition to a "best in class"
virtual experience, Varian's contributions to Intelligent Cancer
Care will be highlighted in eleven presentations including data
from the use of Varian's adaptive radiotherapy system,
Ethos®, for lung, prostate, bladder, upper abdomen, head
& neck cancers, and the first-look data presented by the
recently-formed AI-driven Adaptive Intelligence Consortium.
"Despite the transition to a virtual platform, our entire global
Varian team is looking forward to connecting with ASTRO 2020
attendees and showcasing our innovations that help providers
deliver the best cancer care to patients throughout their entire
journey," said Dow Wilson, Chief Executive Officer of Varian.
"Since its launch at last year's ASTRO, our
Ethos® Therapy has demonstrated significant impact
toward personalizing treatment for patients resulting in 10
featured presentations during this year's meeting."
At this year's virtual event, Varian will participate with a
dynamic booth presence and provide one-on-one product
demonstrations, as well as highlight how it pioneers for the future
with sessions during the ASTRO Innovation Hub. The company will
also have a presence at the American Society of Radiologic
Technologists (ASRT) and Society of Radiation Oncology
Administrators (SROA) concurrent meetings. Attendees can register
for all Varian educational and demo sessions at
https://www.varian.com/resources-support/events/virtual-events
ASTRO attendees will be able to view the following data
presentations featuring Varian products and innovation.
Registration links are available here:
https://www.astro.org/Meetings-and-Education/Micro-Sites/2020/Annual-Meeting/Register
Topic
|
Session/Time and
Day
|
|
Brain
Cancer
|
- Semi-Automated
Hippocampal Sparing Avoidance Whole-Brain Radiotherapy Using a
Commercially Available Artificial Intelligence Toolkit
|
Digital Poster
Q&A
Oct 25, 2:00 p.m.
ET
|
Upper Abdomen
Cancer
|
- Feasibility of
AI-assisted CBCT-guided Stereotactic Online Adaptive Radiotherapy
(CT-STAR) for Upper Abdominal SBRT: Results of a Prospective in
Silico Clinical Trial
|
Oral
Presentations
Oct 25, 9:10 a.m.
ET
|
|
-
Evaluation and validation of artificial intelligence (AI)
delineation models for CBCT-guided stereotactic online adaptive
radiotherapy (STAR) targeting upper abdominal
malignancies
|
Oct 25, 12:20 a.m.
ET
|
Prostate
Cancer
|
- Adaptive
radiotherapy can be applied routinely, using an artificial
intelligence solution, to treat prostate cancer patients
|
Digital Poster
Q&A
Oct 25, 2:15 p.m.
ET
|
Head & Neck
Cancer
|
- Evaluation of
dosimetric quality of auto-generated plans by a novel online
adaptive system for head and neck radiotherapy
|
Digital Posters
Q&A
Oct 25, 2:15 p.m.
ET
|
|
- Evaluation of the
Auto-Segmentation Performance of a Novel Online Adaptive
Radiotherapy System for Head and Neck Cancer Treatment
|
Oct 25, 2:15 p.m.
ET
|
|
- Head and neck quad
shot using CT based adaptive treatment on a ring gantry
LINAC
|
Oct 26, 4:30 p.m.
ET
|
AI and Cancer
Treatment
|
- First AI-driven
Adaptive System-International Consortium lead Failure Mode and
Effect Analysis (FMEA)
|
Oral
Presentation
Oct 26, 12:50 a.m.
ET
|
Bladder
Cancer
|
- Results of a pilot
study on online adaptive radiotherapy of bladder cancer with
artificial intelligence-driven full re-optimization on the anatomy
of the day
|
Oral
Presentation
Oct 27, 1:00 a.m.
ET
|
Lung
Cancer
|
- Improved treatment
quality in stage III lung cancer patients using online adaptive
radiotherapy in a simulation setting
|
Digital Poster
Q&A
Oct 27, 2:00 p.m.
ET
|
Treatment
Planning
|
- Accuracy of the
Treatment Plan Dose Preview Functionality of a Newly Commercially-
Available, CBCT-Based, Online Adaptive Radiotherapy Treatment
System
|
Digital Posters
Q&A
Oct 25, 2:15 p.m.
ET
|
|
- Data-Driven Margin
Determination for Online Adaptive Radiotherapy Using Batch
Automated Planning
|
Oct 25, 2:15 p.m.
ET
|
|
- Plan quality and
fidelity evaluation of CBCT-Guided stereotactic online adaptive
radiotherapy (CT-STAR) with an artificial intelligence (AI) aided
plan re-optimization
|
Oct 28, 2:00 p.m.
ET
|
Clinical
Workflow
|
- Dosimetric Impact
and Required Clinician Time of Online Adaptive Radiotherapy using a
Newly Commercially-Available, CBCT-Based Adaptive Treatment
System
|
Digital Poster
Q&A
Oct 25, 2:15 p.m.
ET
|
|
- Feasibility of
Expediting Radiotherapy Clinical Workflow by Planning on Diagnostic
Images and Adapting on a Commercial Adaptive Radiotherapy
System
|
Oral
Presentation
Oct 28, 3:15 p.m.
ET
|
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 10,000 employees across 70 locations
keep the patient and our clinical partners at the center of our
thinking as we power new victories in cancer care. Because, for
cancer patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
Press Contacts
Aimee
Corso
Health+Commerce
+1 (310) 780-2661
aimee@healthandcommerce.com
Investor Relations Contact
Anshul Maheshwari
Vice President, Investor Relations
+1 (650) 424-5631
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/varian-announces-presence-at-american-society-for-radiation-oncology-astro-annual-meeting-highlighting-advancements-in-intelligent-cancer-care-301154021.html
SOURCE Varian